Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Item
http://www.wikidata.org/entity/Q30845414
Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related SynucleinopathiesGamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease.beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein.Gene therapy progress and prospects: Parkinson's disease.Opposing actions of environmental enrichment and Alzheimer's disease on the expression of hippocampal microRNAs in mouse modelsTargets for neuroprotection in Parkinson's diseaseβ-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood.
P2860

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Item
http://www.wikidata.org/entity/Q30845414
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Development of a new treatment ...... ta-synuclein-derived peptides.
@ast
Development of a new treatment ...... ta-synuclein-derived peptides.
@en
type
label
Development of a new treatment ...... ta-synuclein-derived peptides.
@ast
Development of a new treatment ...... ta-synuclein-derived peptides.
@en
prefLabel
Development of a new treatment ...... ta-synuclein-derived peptides.
@ast
Development of a new treatment ...... ta-synuclein-derived peptides.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Development of a new treatment ...... ta-synuclein-derived peptides.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921